Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas

[1]  T. Miner,et al.  Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk? , 2018, American journal of clinical oncology.

[2]  Christopher J. Miller,et al.  Clinical and pathologic factors associated with subclinical spread of invasive melanoma , 2017, Journal of the American Academy of Dermatology.

[3]  Christopher J. Miller,et al.  Clinical factors associated with subclinical spread of in situ melanoma , 2017, Journal of the American Academy of Dermatology.

[4]  Jennifer L. Schwartz,et al.  Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck Melanoma , 2017, JAMA dermatology.

[5]  A. Klassen,et al.  Patient experiences and outcomes following facial skin cancer surgery: A qualitative study , 2016, The Australasian journal of dermatology.

[6]  B. Pockaj,et al.  Risk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[7]  Christopher J. Miller,et al.  Correlation Between Appropriate Use Criteria and the Frequency of Subclinical Spread or Reconstruction With a Flap or Graft for Melanomas Treated With Mohs Surgery With Melanoma Antigen Recognized by T Cells 1 Immunostaining , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[8]  K. Shannon,et al.  The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case–Control Study , 2016, Annals of Surgical Oncology.

[9]  A. Barbour,et al.  Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia , 2015, Psycho-oncology.

[10]  J. Wayne,et al.  Reducing margins of wide local excision in head and neck melanoma for function and cosmesis: 5‐year local recurrence‐free survival , 2015, Journal of surgical oncology.

[11]  Christopher J. Miller,et al.  Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. , 2015, Journal of the American Academy of Dermatology.

[12]  C. Lohse,et al.  Five-Year Outcomes of Wide Excision and Mohs Micrographic Surgery for Primary Lentigo Maligna in an Academic Practice Cohort , 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[13]  M. Blettner,et al.  Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study , 2015, PloS one.

[14]  M. Singer,et al.  The Safety of and Indications for Immediate Reconstruction of Head and Neck Melanoma Defects: Our Early Experience , 2014, Annals of plastic surgery.

[15]  K. Shannon,et al.  Margins of excision and prognostic factors for cutaneous eyelid melanomas. , 2013, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[16]  M. McCarter,et al.  Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. , 2013, JAMA surgery.

[17]  Timothy L McMurry,et al.  Predicting positive margins in resection of cutaneous melanoma of the head and neck , 2013, The Laryngoscope.

[18]  T. Jahkola,et al.  Outcome following local recurrence or in-transit metastases in cutaneous melanoma , 2012, Melanoma research.

[19]  B. Coldiron,et al.  AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. , 2012, Journal of the American Academy of Dermatology.

[20]  Stephen R. Sullivan,et al.  Head and Neck Malignant Melanoma: Local Recurrence Rate Following Wide Local Excision and Immediate Reconstruction , 2012, Annals of plastic surgery.

[21]  R. Dufresne,et al.  The Operative Management of Melanoma: Where Does Mohs Surgery Fit In? , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[22]  D. Brodland,et al.  The Invasive Growth Potential of Residual Melanoma and Melanoma In Situ , 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[23]  D. Byrd,et al.  Head and Neck Malignant Melanoma: Margin Status and Immediate Reconstruction , 2009, Annals of plastic surgery.

[24]  T. Hieken,et al.  Adverse Outcomes Associated with Noncompliance with Melanoma Treatment Guidelines , 2008, Annals of Surgical Oncology.

[25]  D. Lipsker,et al.  Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. , 2008, Archives of dermatology.

[26]  T. Hieken,et al.  Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables , 2008, Annals of Surgical Oncology.

[27]  G. Giles,et al.  The management of primary cutaneous melanoma in Victoria in 1996 and 2000 , 2007, The Medical journal of Australia.

[28]  M. Walker,et al.  Head and neck melanoma in the sentinel lymph node era. , 2007, Archives of otolaryngology--head & neck surgery.

[29]  B. Pockaj,et al.  Optimal Management and Challenges in Treatment of Upper Facial Melanoma , 2006, Annals of plastic surgery.

[30]  H. Seigler,et al.  Melanoma of the Ear: Treatment and Survival Probabilities Based on 199 Patients , 2006, Annals of plastic surgery.

[31]  C. Garbe,et al.  Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma , 2004, The British journal of dermatology.

[32]  P. Gibbs,et al.  Management of primary cutaneous melanoma of the head and neck: The University of Colorado experience and a review of the literature , 2001, Journal of surgical oncology.

[33]  Jeffrey E. Lee,et al.  Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma , 1998, Annals of Surgical Oncology.

[34]  U. Ringborg,et al.  Outcomes of patients with local recurrence of cutaneous malignant melanoma , 1997, Cancer.

[35]  B. Hanusa,et al.  Surgical margins for excision of primary cutaneous melanoma. , 1997, Journal of the American Academy of Dermatology.

[36]  K. Horgan,et al.  Safe margins in the excision of primary cutaneous melanoma , 1993, The British journal of surgery.

[37]  R. Rapini.  Comparison of methods for checking surgical margins. , 1990, Journal of the American Academy of Dermatology.

[38]  F. Nahai,et al.  The meaning of surgical margins. , 1984, Plastic and reconstructive surgery.

[39]  J. Q. Rosso,et al.  Preoperative Expectations and Values of Patients Undergoing Mohs Micrographic Surgery , 2012 .

[40]  Raymond L. Barnhill,et al.  Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1–4 mm Melanomas , 2001, Annals of Surgical Oncology.

[41]  G. Evans,et al.  The role of soft tissue reconstruction after melanoma resection in the head and neck. , 2001, Head & neck.

[42]  R. Rapini.  False-negative surgical margins. , 1995, Advances in dermatology.

[43]  S. George,et al.  Therapeutic and prognostic considerations of head and neck melanoma. , 1992, Annals of plastic surgery.